HMOX1 and Alzheimer disease: On one hand, in the earlier stages of AD, when HO-1 is still not up-regulated, its induction could have neurotherapeutic effects due to its antioxidant and anti-inflammatory properties derived from its end products biliverdin/bilirubin and CO.